title: Bad to the bone: the effects of liver diseases on bone.
abstract: Metabolic bone disease (MBD) is a relevant complication of long-standing liver disease. It has been described in association with most types of chronic liver disease both cholestatic and non-cholestatic. It can significantly affect morbidity, and quality of life of these patients. Fractures are also associated with an excess mortality. Recently, the issue of MBD in liver disease has been considered to be such an hot topic to be the subject of 2 recent review/guideline articles produced by the British Society of Gastroenterology and the American Gastroenterological Association. Aim of this paper is to summarize some practical issues regarding this topic and to provide a rapid overview of the main pathophysiological and pharmacological aspects.
authors.affiliation: Department of Digestive and Liver Disease, Second School of Medicine, La Sapienza University, Azienda Ospedaliera Sant'Andrea, Rome, Italy. mmarignani@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Marignani
authors.forename: S
authors.initials: S
authors.lastname: Angeletti
authors.forename: G
authors.initials: G
authors.lastname: Capurso
authors.forename: S
authors.initials: S
authors.lastname: Cassetta
authors.forename: G
authors.initials: G
authors.lastname: Delle Fave
mesh_terms: D000328:Adult; D015519:Bone Density; D002779:Cholestasis / Q000150:complications*; D002908:Chronic Disease; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D010018:Osteomalacia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy